Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on April 23, 2026

Apr. 23, 2026

A SHINING STAR CONTRIBUTES TO MAKING AMERICA HEALTHY AGAIN

Indeterminate EIN Presswire

Apr. 23, 2026

Dr. Christina Rahm Recognized Nationally for Building Patent‑Driven Manufacturing Behind The ROOT Brands Products

Indeterminate GlobeNewswire

Apr. 23, 2026

Fiesta Broadway 2026 Celebrates 33 Years in Los Angeles as America’s Largest Cinco de Mayo Festival

Indeterminate EIN Presswire

Apr. 23, 2026

Village Farms Celebrates Historic U.S. Cannabis Rescheduling

Indeterminate GlobeNewswire

Apr. 23, 2026

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire

Apr. 23, 2026

Chemed Reports First-Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 23, 2026

Clarus Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET

Indeterminate GlobeNewswire

Apr. 23, 2026

AVITA Medical to Announce First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 23, 2026

KFSH Wins Webby Award Reflecting a Shift in How Healthcare Engages Global Audiences

Indeterminate EIN Presswire

Apr. 23, 2026

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 23, 2026

Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

Indeterminate GlobeNewswire

Apr. 23, 2026

Trevi Therapeutics to Participate in Upcoming May Events

Indeterminate GlobeNewswire

Apr. 23, 2026

Peloton Interactive, Inc. Announces Date of Third Quarter Fiscal 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Apr. 23, 2026

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Indeterminate GlobeNewswire

Apr. 23, 2026

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

Indeterminate GlobeNewswire

Apr. 23, 2026

Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire

Apr. 23, 2026

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Indeterminate GlobeNewswire

Apr. 23, 2026

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

Indeterminate GlobeNewswire

Apr. 23, 2026

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire

Apr. 23, 2026

Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors

Indeterminate GlobeNewswire